Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Blueprint Medicines Corporation
Ohio State University Comprehensive Cancer Center
Children's Oncology Group
University of Pittsburgh
Eli Lilly and Company
NYU Langone Health
National Institutes of Health Clinical Center (CC)